Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018264 · ClinicalTrials.gov registry record · Phase 4
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
A Phase 4 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT01018264 is a Phase 4 study that has completed, run by University of South Florida. The registered enrollment target is 23 participants.
The verdict
NCT01018264, a Phase 4 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study will assess the effectiveness of solifenacin succinate (VESIcare) in reducing symptoms of overactive bladder in Parkinson's disease (PD) patients.
Interventions
- DRUG placebo
- DRUG solifenacin succinate (VESIcare)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018264
The ClinicalTrials.gov registry entry for NCT01018264 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01018264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018264 about?
NCT01018264 is a clinical study titled "Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease". This study will assess the effectiveness of solifenacin succinate (VESIcare) in reducing symptoms of overactive bladder in Parkinson's disease (PD) patients.
What is the current status of trial NCT01018264?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2010-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01018264?
The interventions under investigation include: placebo (DRUG), solifenacin succinate (VESIcare) (DRUG).
Who is sponsoring clinical trial NCT01018264?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.